News headlines about National Research (NASDAQ:NRCIB) have been trending positive recently, AlphaOne reports. The research firm, a service of Accern, rates the sentiment of press coverage by monitoring more than 20 million blog and news sources. AlphaOne ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. National Research earned a coverage optimism score of 0.30 on AlphaOne’s scale. AlphaOne also gave news stories about the business services provider an impact score of 100 out of 100, indicating that recent press coverage is extremely likely to have an impact on the stock’s share price in the next several days.
National Research (NASDAQ:NRCIB) opened at 43.95 on Friday. The stock’s 50 day moving average is $42.21 and its 200 day moving average is $40.49. National Research has a 52 week low of $32.18 and a 52 week high of $46.37. The company has a market capitalization of $1.07 billion, a PE ratio of 50.75 and a beta of 0.33.
National Research (NASDAQ:NRCIB) last announced its quarterly earnings data on Thursday, May 4th. The business services provider reported $0.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by $0.55. The business had revenue of $30.28 million during the quarter. National Research had a net margin of 18.99% and a return on equity of 35.36%. Analysts predict that National Research will post $0.94 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 14th. Shareholders of record on Friday, June 30th will be paid a $0.60 dividend. The ex-dividend date is Wednesday, June 28th. This represents a $2.40 dividend on an annualized basis and a yield of 5.46%. National Research’s dividend payout ratio (DPR) is presently 500.00%.
Several analysts have commented on NRCIB shares. Zacks Investment Research upgraded shares of National Research from a “hold” rating to a “strong-buy” rating and set a $46.00 target price on the stock in a report on Tuesday, February 21st. First Analysis downgraded shares of National Research from an “overweight” rating to an “equal weight” rating and set a $44.00 target price on the stock. in a report on Thursday, February 16th.
TRADEMARK VIOLATION WARNING: This story was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at https://transcriptdaily.com/2017/05/20/positive-news-coverage-extremely-likely-to-impact-national-research-nrcib-share-price-updated-updated.html.
National Research Co is a business services company in the Health Care Services industry.
Receive News & Ratings for National Research Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Co. and related companies with MarketBeat.com's FREE daily email newsletter.